Insider Stock Trading History of Damaj Bassam


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Damaj Bassam since year 2005. The trader's CIK number is 1478733. At the time of this reporting, Damaj Bassam is the President and CEO of Innovus Pharmaceuticals, Inc. . (stock ticker symbol INNV). See this page for all insider trading activities at Innovus Pharmaceuticals, Inc. .

Note that in the past Damaj Bassam also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Damaj Bassam since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-06-12 INNV Innovus Pharmaceuticals, Inc. Buy 416,841 .32 134,639
2013-02-02 INNV Innovus Pharmaceuticals, Inc. Buy 250,406 .48 118,942
2012-08-21 APRI Nexmed Inc Buy 760 2.77 2,105
2012-08-20 APRI Nexmed Inc Buy 1,500 2.69 4,033

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Damaj Bassam (President and CEO of Innovus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.